New treatments for patients with type 2 diabetes mellitus

Postgraduate Medical Journal

Volumn 72, Issue 853, 1996, Pages 657-662

  Wolffenbuttel, Bruce H R ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Diabetes mellitus type 2; New therapies; Oral antihyperglycaemic agents

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE INHIBITOR; GLIMEPIRIDE; GLUCAGON LIKE PEPTIDE 1 [7-36] AMIDE; GLUCOSE; INSULIN; MIGLITOL; ORAL ANTIDIABETIC AGENT; REPAGLINIDE; ROSIGLITAZONE; TROGLITAZONE;

ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN RELEASE; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PHASE 3 CLINICAL TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029842311     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.72.853.657     Document Type: Article

References (4)

1. Hanssen KF, Dahl-Jorgensen K, Lauritzen T, Feldt-Rasmusssen B, Brinckmann-Hansen O, Decken T. Diabetic control and microvascular complications: the near-normoglycaemic experience. Diabetologia 1986; 29: 677-81.
2. Feldt-Rasmussen B, Mathiesen ER, Jensen T, Lauritzen T, Decken T. Effect of improved metabolic control on loss of kidney function in type I (insulin-dependent) diabetic patients: an update of the Steno studies. Diabetologia 1991; 34: 164-70.
3. Reichard P, Berglund B, Britz A, Cars I, Nilsson BY, Rosenqvisst U. Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 years. J Intern Med 1991; 230: 101-8.
4. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes. N Engl J Med 1993; 329: 977-86.